Immediate Impact
19 standout
Citing Papers
Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents
2024 Standout
Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
2023 Standout
Works of William Houck being referenced
Human epidermal growth factor receptor 2 (HER2) suppression with the addition of lapatinib to trastuzumab in HER2-positive metastatic breast cancer (HALT: LPT112515).
2013
Secondary Leukemias in Refractory Germ Cell Tumor Patients Undergoing Autologous Stem-Cell Transplantation Using High-Dose Etoposide
2004
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| William Houck | 32 | 34 | 8 | 60 | 54 | 4 | 133 | |
| Verena Dreschmann | 26 | 40 | 51 | 29 | 5 | 116 | ||
| Susana Mallea-Gil | 49 | 19 | 132 | 44 | 9 | 175 | ||
| Marion Gambart | 40 | 51 | 1 | 8 | 25 | 6 | 117 | |
| Georgina Gerrard | 17 | 13 | 50 | 12 | 6 | 95 | ||
| Rubin Soomal | 25 | 16 | 80 | 46 | 7 | 122 | ||
| A.J. van der Lely | 72 | 13 | 98 | 36 | 7 | 151 | ||
| Aaron Chevalier | 38 | 11 | 80 | 25 | 6 | 120 | ||
| Bo Wen Cai | 36 | 9 | 44 | 22 | 5 | 201 | ||
| Rami Alrezk | 95 | 53 | 82 | 82 | 4 | 200 | ||
| Louise Southern | 54 | 28 | 9 | 30 | 5 | 150 |
All Works
Loading papers...